Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head.
Spieth
K
K
Zentrum der Dermatologie, Klinikum der J.W. Goethe-Universität, Frankfurt am Main, Germany.
Gille
J
J
Kaufmann
R
R
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000188:drug therapy*; D006394:Hemangiosarcoma / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014212:Tretinoin